Coleus (Coleus forskohlii)

Coleus forskohlii is an Ayurvedic herb whose primary bioactive compound, forskolin, activates adenylyl cyclase to raise intracellular cyclic AMP (cAMP) levels across multiple tissue types. This cAMP elevation drives downstream effects on fat metabolism, insulin signaling, and smooth muscle relaxation.

Origin & History

Coleus forskohlii is a tropical plant native to India, Nepal, and Thailand. It belongs to the Lamiaceae family, and its active extract is derived from the roots, primarily containing forskolin. The extract is standardized to 10% forskolin by weight for clinical use.

Historical & Cultural Context

Coleus forskohlii has its origins in India, Nepal, and Thailand, suggesting potential use in Ayurvedic or traditional South Asian medicine systems. However, specific traditional applications are not documented in the provided research.

Health Benefits

• Significantly reduces fasting insulin levels (Victoria University study, n=41).[1]
• Improves insulin resistance index (HOMA-IR), suggesting enhanced insulin sensitivity (Victoria University study).[4]
• May mitigate weight gain in overweight females, though not conclusive for overall weight loss (randomized controlled trial).[2][6]
• Increases white blood cell counts, which remained within normal ranges, implying potential immune modulation (body composition study).[2]
• Reduces fat cell diameter in animal models, indicating effects on lipid metabolism (mice study).[8]

How It Works

Forskolin directly activates adenylyl cyclase, the enzyme that converts ATP to cyclic AMP (cAMP), bypassing G-protein-coupled receptors to elevate intracellular cAMP broadly. Elevated cAMP activates protein kinase A (PKA), which phosphorylates hormone-sensitive lipase (HSL) to promote lipolysis in adipose tissue and modulates insulin receptor signaling to improve glucose uptake. In pancreatic beta cells, cAMP potentiates glucose-stimulated insulin secretion while simultaneously improving peripheral insulin sensitivity via AMPK pathway crosstalk.

Scientific Research

Clinical trials such as the Victoria University study (PMID not provided) have shown significant improvements in fasting insulin and insulin resistance. Another randomized controlled trial indicated no significant weight loss but potential benefits in overweight females. Animal studies also suggest improved glucose metabolism and lipid modulation.

Clinical Summary

A Victoria University randomized controlled trial (n=41 overweight females) found that Coleus forskohlii supplementation significantly reduced fasting insulin levels and improved the HOMA-IR insulin resistance index compared to placebo, indicating enhanced insulin sensitivity. The same trial suggested a trend toward mitigating weight gain rather than producing active weight loss, limiting conclusions about its efficacy as a standalone fat-loss agent. Evidence base remains modest, with most trials using small sample sizes and short durations of 8–12 weeks. Larger, multi-site RCTs are needed before definitive clinical recommendations can be made.

Nutritional Profile

Coleus forskohlii root extract is primarily valued for its bioactive diterpene compound forskolin, typically standardized to 10–20% concentration in commercial extracts (raw root contains approximately 0.2–0.3% forskolin by dry weight). Forskolin is the principal pharmacologically active constituent, functioning as a direct adenylyl cyclase activator that elevates intracellular cyclic AMP (cAMP). Additional diterpenoids present include coleonol, coleon U, and related labdane-type diterpenes in minor quantities. The root also contains moderate levels of dietary fiber, with small amounts of plant-based protein (approximately 8–12% of dry weight in whole root). Mineral content includes calcium, phosphorus, and potassium in modest concentrations typical of root vegetables, though not nutritionally significant at supplemental doses. Phenolic compounds and flavonoids are present in trace amounts, contributing minor antioxidant activity. Essential oils, including alpha-pinene and beta-caryophyllene, are detected in small quantities. Bioavailability of forskolin is notably enhanced by lipid co-administration due to its lipophilic nature; oral bioavailability from standardized extracts is estimated at 10–17% without lipid carriers. Most human studies use 250 mg of a 10% forskolin extract (delivering 25 mg active forskolin) twice daily. Carbohydrate content of the whole root is moderate, but supplemental extracts are essentially carbohydrate-free. No significant vitamin content has been documented at typical supplemental doses.

Preparation & Dosage

The clinically studied dosage is 250 mg of a standardized extract containing 10% forskolin, taken twice daily 30 minutes before main meals, with a total daily dose of 500 mg (50 mg forskolin) for up to 12 weeks. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Berberine, Cinnamon, Alpha-lipoic acid, Green tea extract, Chromium

Safety & Interactions

Forskolin's vasodilatory and cAMP-elevating properties create clinically relevant interactions with antihypertensive drugs, nitrates, and anticoagulants such as warfarin, potentially amplifying their effects. Individuals taking beta-blockers or calcium channel blockers should use caution, as forskolin may counteract or potentiate cardiovascular effects unpredictably. Common reported side effects include flushing, rapid heart rate, and hypotension, particularly at doses above 50 mg of standardized forskolin daily. Coleus forskohlii is not recommended during pregnancy or breastfeeding due to insufficient safety data and its known smooth muscle relaxant activity.